Matches in Wikidata for { <http://www.wikidata.org/entity/Q92981631> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q92981631 description "article scientifique publié en 2019" @default.
- Q92981631 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92981631 description "scientific article published on 01 June 2019" @default.
- Q92981631 description "wetenschappelijk artikel" @default.
- Q92981631 description "наукова стаття, опублікована 1 червня 2019" @default.
- Q92981631 name "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 name "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 type Item @default.
- Q92981631 label "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 label "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 prefLabel "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 prefLabel "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 P1433 Q92981631-E3630515-CB8D-411D-9330-EC24A2C5ED8F @default.
- Q92981631 P1476 Q92981631-9769157F-ADFB-4C6D-B24B-85B6731F3D33 @default.
- Q92981631 P2093 Q92981631-217F720A-142E-49DD-A43D-004E89496B44 @default.
- Q92981631 P2093 Q92981631-3C404A44-89AE-48A1-9198-2E2E6CD9A62C @default.
- Q92981631 P2093 Q92981631-4804C6D3-F0EC-4D62-BD79-489D8A5FF03A @default.
- Q92981631 P2093 Q92981631-56D1FAC0-CD23-44EB-AB8E-B018ED0C2AC9 @default.
- Q92981631 P2093 Q92981631-5CB23EB0-A4B9-4B7B-A5BD-75D1D07CB458 @default.
- Q92981631 P2093 Q92981631-74988CF0-1DE0-473A-BF89-67D9FC81104A @default.
- Q92981631 P2093 Q92981631-AE5C7BDB-476D-47DE-BDB5-513C7DF73F06 @default.
- Q92981631 P2093 Q92981631-CA097111-2C75-4624-AD16-B82A0137885A @default.
- Q92981631 P304 Q92981631-1BD8D082-8019-4BA7-B898-D3B2B769D494 @default.
- Q92981631 P31 Q92981631-C1FB9CDE-21F5-4426-BA5E-F3FE07FB19A4 @default.
- Q92981631 P356 Q92981631-B051A6AB-44AE-404F-BEF7-14480F65E298 @default.
- Q92981631 P433 Q92981631-AF7E842E-8534-4006-8AAA-BEEF1603E26C @default.
- Q92981631 P478 Q92981631-AEC4A6C3-7099-4C53-944F-336E578E7BF1 @default.
- Q92981631 P577 Q92981631-62227DA7-4F1F-4E4B-85C0-9F20F12329D6 @default.
- Q92981631 P698 Q92981631-CF61A203-657A-4636-96A1-B787A6FE3685 @default.
- Q92981631 P921 Q92981631-B8428F0C-264F-4F4E-BEAB-EA3305FF8D7C @default.
- Q92981631 P356 23258160-20190605-01 @default.
- Q92981631 P698 31233150 @default.
- Q92981631 P1433 Q27724588 @default.
- Q92981631 P1476 "Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP" @default.
- Q92981631 P2093 "Bree Andrews" @default.
- Q92981631 P2093 "Colleen Peyton" @default.
- Q92981631 P2093 "Katherine Lewis" @default.
- Q92981631 P2093 "Mark J Greenwald" @default.
- Q92981631 P2093 "Michael D Schreiber" @default.
- Q92981631 P2093 "Michael E Msall" @default.
- Q92981631 P2093 "Michael P Blair" @default.
- Q92981631 P2093 "Sarah Hilkert Rodriguez" @default.
- Q92981631 P304 "337-343" @default.
- Q92981631 P31 Q13442814 @default.
- Q92981631 P356 "10.3928/23258160-20190605-01" @default.
- Q92981631 P433 "6" @default.
- Q92981631 P478 "50" @default.
- Q92981631 P577 "2019-06-01T00:00:00Z" @default.
- Q92981631 P698 "31233150" @default.
- Q92981631 P921 Q413299 @default.